These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1664829)

  • 41. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.
    Wickman PA; Black JA; Moland ES; Thomson KS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2255-7. PubMed ID: 16723599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The selection and frequency of streptococci with decreased susceptibility to ofloxacin compared with other quinolones.
    Piddock LJ; Wise R
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():45-51. PubMed ID: 3182461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
    Chodosh S
    Chest; 1991 Dec; 100(6):1497-502. PubMed ID: 1659975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
    [No Abstract]   [Full Text] [Related]  

  • 45. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia.
    Veber B; Vallée E; Desmonts JM; Pocidalo JJ; Azoulay-Dupuis E
    J Antimicrob Chemother; 1993 Sep; 32(3):473-82. PubMed ID: 8262870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of temafloxacin in the community setting: an overview.
    Ball P
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():121-30. PubMed ID: 1664825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Vallée E; Bedos JP; Muffat-Joly M; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1024-8. PubMed ID: 1656849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
    Thys JP; Jacobs F; Byl B
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):304-15. PubMed ID: 1864291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.
    Kemmerich B; Small GJ; Pennington JE
    Antimicrob Agents Chemother; 1986 Mar; 29(3):395-9. PubMed ID: 2940970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia.
    Carbon C; Léophonte P; Petitpretz P; Chauvin JP; Hazebroucq J
    Antimicrob Agents Chemother; 1992 Apr; 36(4):833-9. PubMed ID: 1323954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.
    Nau R; Schmidt T; Kaye K; Froula JL; Täuber MG
    Antimicrob Agents Chemother; 1995 Mar; 39(3):593-7. PubMed ID: 7793857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of temafloxacin on the pharmacokinetics of theophylline.
    Ruff F; Santais MC; Callens E; Chauvin JP; Hazebroucq J
    Am J Med; 1991 Dec; 91(6A):76S-80S. PubMed ID: 1662899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of organ-specific toxicity of temafloxacin in animals and humans.
    Krasula RW; Pernet AG
    Am J Med; 1991 Dec; 91(6A):38S-41S. PubMed ID: 1662894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
    Gelber RH; Iranmanesh A; Murray L; Siu P; Tsang M
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2544-7. PubMed ID: 1336951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effect of temafloxacin, ciprofloxacin, or placebo on cerebral blood flow, glucose, and oxygen metabolism in healthy subjects by means of positron emission tomography.
    Bednarczyk EM; Green JA; Nelson AD; Leisure GA; Little D; Adler LP; Berridge MS; Panacek EA; Miraldi FD
    Clin Pharmacol Ther; 1991 Aug; 50(2):165-71. PubMed ID: 1868678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacodynamics and pharmacokinetics of A-80556 using microdialysis in a Streptococcus pneumoniae meningitis model.
    Destache CJ; Pakiz CB; Stoysich AM
    J Antimicrob Chemother; 1996 Dec; 38(6):977-85. PubMed ID: 9023645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.
    Vogel F; Lode H
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():81-6. PubMed ID: 1664833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of temafloxacin versus ciprofloxacin or amoxicillin for lower respiratory tract infections in smokers and the elderly.
    Davey PG
    Am J Med; 1991 Dec; 91(6A):101S-105S. PubMed ID: 1662877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.